{
    "info": {
        "nct_id": "NCT03715933",
        "official_title": "An Open-Label, Multicenter, First-in-Human, Phase 1 Dose-Escalation and Multicohort Expansion Study of INBRX-109 in Subjects with Locally Advanced or Metastatic Solid Tumors Including Sarcomas",
        "inclusion_criteria": "1. Males or females aged ≥12 to less than 85 years for Ewing sarcoma and 18 to less than 85 years of age for other tumors.\n2. Part 3 combination therapy expansion tumor types:\n\n   * Histologically confirmed Ewing sarcoma with a classical fusion: Patients with locally advanced or metastatic, unresectable, relapsed, or refractory disease who have received at least 1 but no more than 2 prior lines of systemic treatment with a preferred first line chemotherapy regimens.\n   * Colorectal adenocarcinoma: Patients with locally advanced or metastatic, unresectable disease, who have received at least 2 but no more than 3 prior lines of systemic therapy.\n3. Measurable disease as defined by RECISTv1.1 (or modified RECIST for mesothelioma) criteria.\n4. Adequate hematologic, coagulation, hepatic and renal function as defined per protocol.\n5. Eastern Cooperative Oncology Group Performance Status (ECOG PS) score of 0 or 1, or Karnofsky Performance Status score of ≥60, or Lansky Play-Performance Scale for Children score ≥60 (for patients less than 16 years).\n6. Estimated life expectancy of at least 12 weeks.\n7. Availability of archival tissue or fresh cancer biopsy are mandatory.\nHealthy volunteers allowed\nMust have minimum age of 12 Years\nMust have maximum age of 85 Years",
        "exclusion_criteria": "1. Prior treatment with or exposure to DR5 agonists.\n2. Receipt of any anticancer therapy (including investigational agents) within 4 weeks or within 5 half-lives prior to the first dose of study treatment. Exceptions per protocol.\n3. Allergy or sensitivity to INBRX-109 or known allergies to CHO-produced antibodies.\n4. Receipt of radiotherapy within 4 weeks prior to the first dose of study treatment, and liver-directed within 12 months prior to the first dose of study drug.\n5. Subject has undergone allogeneic hematopoietic stem cell or bone marrow transplantation within the last 5 years. Exceptions per protocol.\n6. Prior or concurrent malignancies. Exceptions per protocol.\n7. Hematologic malignancies.\n8. Symptomatic active primary CNS tumors, leptomeningeal disease, and CNS metastases. Exceptions per protocol. Patients with any evidence or history of multiple sclerosis (MS) or other demyelinating disorders are excluded.\n9. Chronic liver diseases including fatty liver. Exception: Patients < 45 years old with fatty liver disease may be accepted as long as adequate hepatic function as defined in the inclusion/exclusion criteria is confirmed.\n10. Acute viral or toxic liver disease within 12 months prior to the first dose of study drug.\n11. Evidence or history of hepatitis B, hepatitis C, or human immunodeficiency virus (HIV) infection.\n12. Known sensitivity or contraindications to the following drugs:\n\n    * Ewing sarcoma: irinotecan or TMZ\n    * colorectal adenocarcinoma: FU, leucovorin, or irinotecan\n13. Clinically significant cardiac condition, including myocardial infarction, uncontrolled angina, cerebrovascular accident, or other acute uncontrolled heart disease less than 3 months prior to enrollment.\n14. Acute, hemodynamically significant deep vein thrombosis or clinically significant pulmonary embolism not resolved or stable for at least 3 months prior to the start of study treatment.\n15. Major surgery within 4 weeks prior to enrollment on this trial.\n16. Systemic infection requiring antibiotics within 2 weeks prior to the first dose of study drug.\n17. Other exclusion criteria per protocol.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "identified_line": {
                "line": "6. Estimated life expectancy of at least 12 weeks.",
                "criterions": [
                    {
                        "exact_snippets": "Estimated life expectancy of at least 12 weeks",
                        "criterion": "life expectancy",
                        "requirement": {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 12,
                                "unit": "weeks"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Estimated life expectancy of at least 12 weeks",
                        "criterion": "life expectancy",
                        "requirement": {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 12,
                                "unit": "weeks"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "3. Measurable disease as defined by RECISTv1.1 (or modified RECIST for mesothelioma) criteria.",
                "criterions": [
                    {
                        "exact_snippets": "Measurable disease as defined by RECISTv1.1 (or modified RECIST for mesothelioma) criteria",
                        "criterion": "measurable disease",
                        "requirement": {
                            "requirement_type": "definition",
                            "expected_value": "RECISTv1.1 (or modified RECIST for mesothelioma) criteria"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Measurable disease as defined by RECISTv1.1 (or modified RECIST for mesothelioma) criteria",
                        "criterion": "measurable disease",
                        "requirement": {
                            "requirement_type": "definition",
                            "expected_value": "RECISTv1.1 (or modified RECIST for mesothelioma) criteria"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "7. Availability of archival tissue or fresh cancer biopsy are mandatory.",
                "criterions": [
                    {
                        "exact_snippets": "Availability of archival tissue ... are mandatory",
                        "criterion": "archival tissue",
                        "requirement": {
                            "requirement_type": "availability",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Availability of ... fresh cancer biopsy are mandatory",
                        "criterion": "fresh cancer biopsy",
                        "requirement": {
                            "requirement_type": "availability",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Availability of archival tissue ... are mandatory",
                        "criterion": "archival tissue",
                        "requirement": {
                            "requirement_type": "availability",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Availability of ... fresh cancer biopsy are mandatory",
                        "criterion": "fresh cancer biopsy",
                        "requirement": {
                            "requirement_type": "availability",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "4. Adequate hematologic, coagulation, hepatic and renal function as defined per protocol.",
                "criterions": [
                    {
                        "exact_snippets": "Adequate hematologic ... function as defined per protocol",
                        "criterion": "hematologic function",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Adequate ... coagulation ... function as defined per protocol",
                        "criterion": "coagulation function",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Adequate ... hepatic ... function as defined per protocol",
                        "criterion": "hepatic function",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Adequate ... renal function as defined per protocol",
                        "criterion": "renal function",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Adequate hematologic ... function as defined per protocol",
                        "criterion": "hematologic function",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Adequate ... coagulation ... function as defined per protocol",
                        "criterion": "coagulation function",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Adequate ... hepatic ... function as defined per protocol",
                        "criterion": "hepatic function",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Adequate ... renal function as defined per protocol",
                        "criterion": "renal function",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Must have maximum age of 85 Years",
                "criterions": [
                    {
                        "exact_snippets": "maximum age of 85 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 85,
                                "unit": "years"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "maximum age of 85 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 85,
                                "unit": "years"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Must have minimum age of 12 Years",
                "criterions": [
                    {
                        "exact_snippets": "minimum age of 12 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 12,
                                "unit": "Years"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "minimum age of 12 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 12,
                                "unit": "Years"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "2. Part 3 combination therapy expansion tumor types:",
                "criterions": [
                    {
                        "exact_snippets": "Part 3 combination therapy expansion tumor types",
                        "criterion": "tumor type",
                        "requirement": {
                            "requirement_type": "inclusion in Part 3 combination therapy expansion",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Part 3 combination therapy expansion tumor types",
                        "criterion": "tumor type",
                        "requirement": {
                            "requirement_type": "inclusion in Part 3 combination therapy expansion",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Healthy volunteers allowed",
                "criterions": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "5. Eastern Cooperative Oncology Group Performance Status (ECOG PS) score of 0 or 1, or Karnofsky Performance Status score of ≥60, or Lansky Play-Performance Scale for Children score ≥60 (for patients less than 16 years).",
                "criterions": [
                    {
                        "exact_snippets": "Eastern Cooperative Oncology Group Performance Status (ECOG PS) score of 0 or 1",
                        "criterion": "ECOG Performance Status score",
                        "requirement": {
                            "requirement_type": "score",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": ""
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 1,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    },
                    {
                        "exact_snippets": "Karnofsky Performance Status score of ≥60",
                        "criterion": "Karnofsky Performance Status score",
                        "requirement": {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": ""
                            }
                        }
                    },
                    {
                        "exact_snippets": "Lansky Play-Performance Scale for Children score ≥60 (for patients less than 16 years)",
                        "criterion": "Lansky Play-Performance Scale for Children score",
                        "requirement": {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": ""
                            }
                        }
                    },
                    {
                        "exact_snippets": "Lansky Play-Performance Scale for Children score ≥60 (for patients less than 16 years)",
                        "criterion": "Lansky Play-Performance Scale for Children score",
                        "requirement": {
                            "requirement_type": "age",
                            "expected_value": {
                                "operator": "<",
                                "value": 16,
                                "unit": "years"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Eastern Cooperative Oncology Group Performance Status (ECOG PS) score of 0 or 1",
                        "criterion": "ECOG Performance Status score",
                        "requirement": {
                            "requirement_type": "score",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": ""
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 1,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    },
                    {
                        "exact_snippets": "Karnofsky Performance Status score of ≥60",
                        "criterion": "Karnofsky Performance Status score",
                        "requirement": {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": ""
                            }
                        }
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Lansky Play-Performance Scale for Children score ≥60 (for patients less than 16 years)",
                                "criterion": "Lansky Play-Performance Scale for Children score",
                                "requirement": {
                                    "requirement_type": "score",
                                    "expected_value": {
                                        "operator": ">=",
                                        "value": 60,
                                        "unit": ""
                                    }
                                }
                            },
                            {
                                "exact_snippets": "Lansky Play-Performance Scale for Children score ≥60 (for patients less than 16 years)",
                                "criterion": "Lansky Play-Performance Scale for Children score",
                                "requirement": {
                                    "requirement_type": "age",
                                    "expected_value": {
                                        "operator": "<",
                                        "value": 16,
                                        "unit": "years"
                                    }
                                }
                            }
                        ]
                    }
                ]
            }
        }
    ],
    "exclusion_lines": [
        {
            "identified_line": {
                "line": "17. Other exclusion criteria per protocol.",
                "criterions": [
                    {
                        "exact_snippets": "Other exclusion criteria per protocol.",
                        "criterion": "other exclusion criteria per protocol",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Other exclusion criteria per protocol.",
                        "criterion": "other exclusion criteria per protocol",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "15. Major surgery within 4 weeks prior to enrollment on this trial.",
                "criterions": [
                    {
                        "exact_snippets": "Major surgery within 4 weeks prior to enrollment on this trial.",
                        "criterion": "major surgery",
                        "requirement": {
                            "requirement_type": "time since surgery",
                            "expected_value": {
                                "operator": ">=",
                                "value": 4,
                                "unit": "weeks"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "not_criteria": {
                    "exact_snippets": "Major surgery within 4 weeks prior to enrollment on this trial.",
                    "criterion": "major surgery",
                    "requirement": {
                        "requirement_type": "time since surgery",
                        "expected_value": {
                            "operator": ">=",
                            "value": 4,
                            "unit": "weeks"
                        }
                    }
                }
            }
        },
        {
            "identified_line": {
                "line": "1. Prior treatment with or exposure to DR5 agonists.",
                "criterions": [
                    {
                        "exact_snippets": "Prior treatment with or exposure to DR5 agonists",
                        "criterion": "DR5 agonists",
                        "requirement": {
                            "requirement_type": "prior treatment or exposure",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "not_criteria": {
                    "exact_snippets": "Prior treatment with or exposure to DR5 agonists",
                    "criterion": "DR5 agonists",
                    "requirement": {
                        "requirement_type": "prior treatment or exposure",
                        "expected_value": true
                    }
                }
            }
        },
        {
            "identified_line": {
                "line": "12. Known sensitivity or contraindications to the following drugs:",
                "criterions": [
                    {
                        "exact_snippets": "Known sensitivity or contraindications to the following drugs",
                        "criterion": "sensitivity or contraindications to specified drugs",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Known sensitivity or contraindications to the following drugs",
                        "criterion": "sensitivity or contraindications to specified drugs",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "5. Subject has undergone allogeneic hematopoietic stem cell or bone marrow transplantation within the last 5 years. Exceptions per protocol.",
                "criterions": [
                    {
                        "exact_snippets": "Subject has undergone allogeneic hematopoietic stem cell or bone marrow transplantation within the last 5 years",
                        "criterion": "allogeneic hematopoietic stem cell or bone marrow transplantation",
                        "requirement": {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 5,
                                "unit": "years"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Subject has undergone allogeneic hematopoietic stem cell or bone marrow transplantation within the last 5 years",
                        "criterion": "allogeneic hematopoietic stem cell or bone marrow transplantation",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Subject has undergone allogeneic hematopoietic stem cell or bone marrow transplantation within the last 5 years",
                                "criterion": "allogeneic hematopoietic stem cell or bone marrow transplantation",
                                "requirement": {
                                    "requirement_type": "history",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "Subject has undergone allogeneic hematopoietic stem cell or bone marrow transplantation within the last 5 years",
                                "criterion": "allogeneic hematopoietic stem cell or bone marrow transplantation",
                                "requirement": {
                                    "requirement_type": "recency",
                                    "expected_value": {
                                        "operator": "<=",
                                        "value": 5,
                                        "unit": "years"
                                    }
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "14. Acute, hemodynamically significant deep vein thrombosis or clinically significant pulmonary embolism not resolved or stable for at least 3 months prior to the start of study treatment.",
                "criterions": [
                    {
                        "exact_snippets": "Acute, hemodynamically significant deep vein thrombosis ... not resolved or stable for at least 3 months prior to the start of study treatment",
                        "criterion": "deep vein thrombosis",
                        "requirement": {
                            "requirement_type": "acuteness",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Acute, hemodynamically significant deep vein thrombosis ... not resolved or stable for at least 3 months prior to the start of study treatment",
                        "criterion": "deep vein thrombosis",
                        "requirement": {
                            "requirement_type": "hemodynamic significance",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Acute, hemodynamically significant deep vein thrombosis ... not resolved or stable for at least 3 months prior to the start of study treatment",
                        "criterion": "deep vein thrombosis",
                        "requirement": {
                            "requirement_type": "resolution or stability duration",
                            "expected_value": {
                                "operator": "<",
                                "value": 3,
                                "unit": "months"
                            }
                        }
                    },
                    {
                        "exact_snippets": "clinically significant pulmonary embolism not resolved or stable for at least 3 months prior to the start of study treatment",
                        "criterion": "pulmonary embolism",
                        "requirement": {
                            "requirement_type": "clinical significance",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "clinically significant pulmonary embolism not resolved or stable for at least 3 months prior to the start of study treatment",
                        "criterion": "pulmonary embolism",
                        "requirement": {
                            "requirement_type": "resolution or stability duration",
                            "expected_value": {
                                "operator": "<",
                                "value": 3,
                                "unit": "months"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Acute, hemodynamically significant deep vein thrombosis ... not resolved or stable for at least 3 months prior to the start of study treatment",
                                "criterion": "deep vein thrombosis",
                                "requirement": {
                                    "requirement_type": "acuteness",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "Acute, hemodynamically significant deep vein thrombosis ... not resolved or stable for at least 3 months prior to the start of study treatment",
                                "criterion": "deep vein thrombosis",
                                "requirement": {
                                    "requirement_type": "hemodynamic significance",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "Acute, hemodynamically significant deep vein thrombosis ... not resolved or stable for at least 3 months prior to the start of study treatment",
                                "criterion": "deep vein thrombosis",
                                "requirement": {
                                    "requirement_type": "resolution or stability duration",
                                    "expected_value": {
                                        "operator": "<",
                                        "value": 3,
                                        "unit": "months"
                                    }
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "clinically significant pulmonary embolism not resolved or stable for at least 3 months prior to the start of study treatment",
                                "criterion": "pulmonary embolism",
                                "requirement": {
                                    "requirement_type": "clinical significance",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "clinically significant pulmonary embolism not resolved or stable for at least 3 months prior to the start of study treatment",
                                "criterion": "pulmonary embolism",
                                "requirement": {
                                    "requirement_type": "resolution or stability duration",
                                    "expected_value": {
                                        "operator": "<",
                                        "value": 3,
                                        "unit": "months"
                                    }
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "3. Allergy or sensitivity to INBRX-109 or known allergies to CHO-produced antibodies.",
                "criterions": [
                    {
                        "exact_snippets": "Allergy or sensitivity to INBRX-109",
                        "criterion": "allergy or sensitivity to INBRX-109",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "known allergies to CHO-produced antibodies",
                        "criterion": "allergy to CHO-produced antibodies",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Allergy or sensitivity to INBRX-109",
                        "criterion": "allergy or sensitivity to INBRX-109",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "known allergies to CHO-produced antibodies",
                        "criterion": "allergy to CHO-produced antibodies",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "16. Systemic infection requiring antibiotics within 2 weeks prior to the first dose of study drug.",
                "criterions": [
                    {
                        "exact_snippets": "Systemic infection requiring antibiotics within 2 weeks prior to the first dose of study drug.",
                        "criterion": "systemic infection requiring antibiotics",
                        "requirement": {
                            "requirement_type": "presence_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "weeks prior to first dose of study drug"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Systemic infection requiring antibiotics within 2 weeks prior to the first dose of study drug.",
                        "criterion": "systemic infection requiring antibiotics",
                        "requirement": {
                            "requirement_type": "presence_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "weeks prior to first dose of study drug"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "11. Evidence or history of hepatitis B, hepatitis C, or human immunodeficiency virus (HIV) infection.",
                "criterions": [
                    {
                        "exact_snippets": "Evidence or history of hepatitis B",
                        "criterion": "hepatitis B infection",
                        "requirement": {
                            "requirement_type": "evidence or history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Evidence or history of hepatitis C",
                        "criterion": "hepatitis C infection",
                        "requirement": {
                            "requirement_type": "evidence or history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Evidence or history of ... human immunodeficiency virus (HIV) infection",
                        "criterion": "HIV infection",
                        "requirement": {
                            "requirement_type": "evidence or history",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Evidence or history of hepatitis B",
                        "criterion": "hepatitis B infection",
                        "requirement": {
                            "requirement_type": "evidence or history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Evidence or history of hepatitis C",
                        "criterion": "hepatitis C infection",
                        "requirement": {
                            "requirement_type": "evidence or history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Evidence or history of ... human immunodeficiency virus (HIV) infection",
                        "criterion": "HIV infection",
                        "requirement": {
                            "requirement_type": "evidence or history",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "4. Receipt of radiotherapy within 4 weeks prior to the first dose of study treatment, and liver-directed within 12 months prior to the first dose of study drug.",
                "criterions": [
                    {
                        "exact_snippets": "Receipt of radiotherapy within 4 weeks prior to the first dose of study treatment",
                        "criterion": "radiotherapy",
                        "requirement": {
                            "requirement_type": "receipt_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 4,
                                "unit": "weeks prior to first dose of study treatment"
                            }
                        }
                    },
                    {
                        "exact_snippets": "liver-directed within 12 months prior to the first dose of study drug",
                        "criterion": "liver-directed radiotherapy",
                        "requirement": {
                            "requirement_type": "receipt_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 12,
                                "unit": "months prior to first dose of study drug"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Receipt of radiotherapy within 4 weeks prior to the first dose of study treatment",
                        "criterion": "radiotherapy",
                        "requirement": {
                            "requirement_type": "receipt_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 4,
                                "unit": "weeks prior to first dose of study treatment"
                            }
                        }
                    },
                    {
                        "exact_snippets": "liver-directed within 12 months prior to the first dose of study drug",
                        "criterion": "liver-directed radiotherapy",
                        "requirement": {
                            "requirement_type": "receipt_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 12,
                                "unit": "months prior to first dose of study drug"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "10. Acute viral or toxic liver disease within 12 months prior to the first dose of study drug.",
                "criterions": [
                    {
                        "exact_snippets": "Acute viral or toxic liver disease within 12 months prior to the first dose of study drug.",
                        "criterion": "acute viral liver disease",
                        "requirement": {
                            "requirement_type": "presence_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 12,
                                "unit": "months"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Acute viral or toxic liver disease within 12 months prior to the first dose of study drug.",
                        "criterion": "acute toxic liver disease",
                        "requirement": {
                            "requirement_type": "presence_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 12,
                                "unit": "months"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Acute viral or toxic liver disease within 12 months prior to the first dose of study drug.",
                        "criterion": "acute viral liver disease",
                        "requirement": {
                            "requirement_type": "presence_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 12,
                                "unit": "months"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Acute viral or toxic liver disease within 12 months prior to the first dose of study drug.",
                        "criterion": "acute toxic liver disease",
                        "requirement": {
                            "requirement_type": "presence_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 12,
                                "unit": "months"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "7. Hematologic malignancies.",
                "criterions": [
                    {
                        "exact_snippets": "Hematologic malignancies.",
                        "criterion": "hematologic malignancy",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "not_criteria": {
                    "exact_snippets": "Hematologic malignancies.",
                    "criterion": "hematologic malignancy",
                    "requirement": {
                        "requirement_type": "presence",
                        "expected_value": true
                    }
                }
            }
        },
        {
            "identified_line": {
                "line": "2. Receipt of any anticancer therapy (including investigational agents) within 4 weeks or within 5 half-lives prior to the first dose of study treatment. Exceptions per protocol.",
                "criterions": [
                    {
                        "exact_snippets": "Receipt of any anticancer therapy (including investigational agents) within 4 weeks or within 5 half-lives prior to the first dose of study treatment",
                        "criterion": "anticancer therapy (including investigational agents)",
                        "requirement": {
                            "requirement_type": "receipt within time window",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 4,
                                        "unit": "weeks"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 5,
                                        "unit": "half-lives"
                                    }
                                ]
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Receipt of any anticancer therapy (including investigational agents) within 4 weeks or within 5 half-lives prior to the first dose of study treatment",
                        "criterion": "anticancer therapy (including investigational agents)",
                        "requirement": {
                            "requirement_type": "receipt within time window",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 4,
                                        "unit": "weeks"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 5,
                                        "unit": "half-lives"
                                    }
                                ]
                            }
                        }
                    }
                ]
            }
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "identified_line": {
                "line": "1. Males or females aged ≥12 to less than 85 years for Ewing sarcoma and 18 to less than 85 years of age for other tumors.",
                "criterions": [
                    {
                        "exact_snippets": "Males or females",
                        "criterion": "sex",
                        "requirement": {
                            "requirement_type": "allowed_values",
                            "expected_value": [
                                "male",
                                "female"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "aged ≥12 to less than 85 years for Ewing sarcoma",
                        "criterion": "age (Ewing sarcoma)",
                        "requirement": {
                            "requirement_type": "age_range",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 12,
                                        "unit": "years"
                                    },
                                    {
                                        "operator": "<",
                                        "value": 85,
                                        "unit": "years"
                                    }
                                ]
                            }
                        }
                    },
                    {
                        "exact_snippets": "18 to less than 85 years of age for other tumors",
                        "criterion": "age (other tumors)",
                        "requirement": {
                            "requirement_type": "age_range",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 18,
                                        "unit": "years"
                                    },
                                    {
                                        "operator": "<",
                                        "value": 85,
                                        "unit": "years"
                                    }
                                ]
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "* Histologically confirmed Ewing sarcoma with a classical fusion: Patients with locally advanced or metastatic, unresectable, relapsed, or refractory disease who have received at least 1 but no more than 2 prior lines of systemic treatment with a preferred first line chemotherapy regimens.",
                "criterions": [
                    {
                        "exact_snippets": "Histologically confirmed Ewing sarcoma with a classical fusion",
                        "criterion": "Ewing sarcoma diagnosis",
                        "requirement": {
                            "requirement_type": "histological confirmation",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Histologically confirmed Ewing sarcoma with a classical fusion",
                        "criterion": "Ewing sarcoma diagnosis",
                        "requirement": {
                            "requirement_type": "fusion type",
                            "expected_value": "classical"
                        }
                    },
                    {
                        "exact_snippets": "locally advanced or metastatic, unresectable, relapsed, or refractory disease",
                        "criterion": "disease status",
                        "requirement": {
                            "requirement_type": "status",
                            "expected_value": [
                                "locally advanced",
                                "metastatic",
                                "unresectable",
                                "relapsed",
                                "refractory"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "have received at least 1 but no more than 2 prior lines of systemic treatment",
                        "criterion": "prior lines of systemic treatment",
                        "requirement": {
                            "requirement_type": "number of prior lines",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 1,
                                        "unit": "lines"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": "lines"
                                    }
                                ]
                            }
                        }
                    },
                    {
                        "exact_snippets": "with a preferred first line chemotherapy regimens",
                        "criterion": "first line chemotherapy regimen",
                        "requirement": {
                            "requirement_type": "regimen type",
                            "expected_value": "preferred first line chemotherapy"
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "* Colorectal adenocarcinoma: Patients with locally advanced or metastatic, unresectable disease, who have received at least 2 but no more than 3 prior lines of systemic therapy.",
                "criterions": [
                    {
                        "exact_snippets": "Colorectal adenocarcinoma",
                        "criterion": "colorectal adenocarcinoma",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "locally advanced or metastatic, unresectable disease",
                        "criterion": "disease stage and resectability",
                        "requirement": {
                            "requirement_type": "stage",
                            "expected_value": [
                                "locally advanced",
                                "metastatic"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "locally advanced or metastatic, unresectable disease",
                        "criterion": "disease stage and resectability",
                        "requirement": {
                            "requirement_type": "resectability",
                            "expected_value": "unresectable"
                        }
                    },
                    {
                        "exact_snippets": "have received at least 2 but no more than 3 prior lines of systemic therapy",
                        "criterion": "prior lines of systemic therapy",
                        "requirement": {
                            "requirement_type": "number of prior lines",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 2,
                                        "unit": "lines"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 3,
                                        "unit": "lines"
                                    }
                                ]
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        }
    ],
    "failed_exclusion": [
        {
            "identified_line": {
                "line": "* Ewing sarcoma: irinotecan or TMZ",
                "criterions": [
                    {
                        "exact_snippets": "Ewing sarcoma",
                        "criterion": "Ewing sarcoma",
                        "requirement": {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "irinotecan or TMZ",
                        "criterion": "prior treatment with irinotecan or TMZ",
                        "requirement": {
                            "requirement_type": "prior treatment",
                            "expected_value": [
                                "irinotecan",
                                "TMZ"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "8. Symptomatic active primary CNS tumors, leptomeningeal disease, and CNS metastases. Exceptions per protocol. Patients with any evidence or history of multiple sclerosis (MS) or other demyelinating disorders are excluded.",
                "criterions": [
                    {
                        "exact_snippets": "Symptomatic active primary CNS tumors",
                        "criterion": "primary CNS tumors",
                        "requirement": {
                            "requirement_type": "symptomatic and active presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "leptomeningeal disease",
                        "criterion": "leptomeningeal disease",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "CNS metastases",
                        "criterion": "CNS metastases",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "any evidence or history of multiple sclerosis (MS)",
                        "criterion": "multiple sclerosis (MS)",
                        "requirement": {
                            "requirement_type": "evidence or history",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "other demyelinating disorders",
                        "criterion": "other demyelinating disorders",
                        "requirement": {
                            "requirement_type": "evidence or history",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "or_criteria": [
                            {
                                "exact_snippets": "Symptomatic active primary CNS tumors",
                                "criterion": "primary CNS tumors",
                                "requirement": {
                                    "requirement_type": "symptomatic and active presence",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "leptomeningeal disease",
                                "criterion": "leptomeningeal disease",
                                "requirement": {
                                    "requirement_type": "presence",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "CNS metastases",
                                "criterion": "CNS metastases",
                                "requirement": {
                                    "requirement_type": "presence",
                                    "expected_value": true
                                }
                            }
                        ]
                    },
                    {
                        "or_criteria": [
                            {
                                "exact_snippets": "any evidence or history of multiple sclerosis (MS)",
                                "criterion": "multiple sclerosis (MS)",
                                "requirement": {
                                    "requirement_type": "evidence or history",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "other demyelinating disorders",
                                "criterion": "other demyelinating disorders",
                                "requirement": {
                                    "requirement_type": "evidence or history",
                                    "expected_value": true
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* colorectal adenocarcinoma: FU, leucovorin, or irinotecan",
                "criterions": [
                    {
                        "exact_snippets": "colorectal adenocarcinoma",
                        "criterion": "colorectal adenocarcinoma",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "FU, leucovorin, or irinotecan",
                        "criterion": "prior treatment with FU, leucovorin, or irinotecan",
                        "requirement": {
                            "requirement_type": "prior treatment",
                            "expected_value": [
                                "FU",
                                "leucovorin",
                                "irinotecan"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "9. Chronic liver diseases including fatty liver. Exception: Patients < 45 years old with fatty liver disease may be accepted as long as adequate hepatic function as defined in the inclusion/exclusion criteria is confirmed.",
                "criterions": [
                    {
                        "exact_snippets": "Chronic liver diseases including fatty liver",
                        "criterion": "chronic liver diseases",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "fatty liver",
                        "criterion": "fatty liver disease",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "Patients < 45 years old with fatty liver disease may be accepted as long as adequate hepatic function ... is confirmed",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": "<",
                                "value": 45,
                                "unit": "years"
                            }
                        }
                    },
                    {
                        "exact_snippets": "adequate hepatic function as defined in the inclusion/exclusion criteria is confirmed",
                        "criterion": "hepatic function",
                        "requirement": {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Chronic liver diseases including fatty liver",
                                "criterion": "chronic liver diseases",
                                "requirement": {
                                    "requirement_type": "presence",
                                    "expected_value": true
                                }
                            },
                            {
                                "not_criteria": {
                                    "and_criteria": [
                                        {
                                            "exact_snippets": "fatty liver",
                                            "criterion": "fatty liver disease",
                                            "requirement": {
                                                "requirement_type": "presence",
                                                "expected_value": true
                                            }
                                        },
                                        {
                                            "exact_snippets": "Patients < 45 years old with fatty liver disease may be accepted as long as adequate hepatic function ... is confirmed",
                                            "criterion": "age",
                                            "requirement": {
                                                "requirement_type": "value",
                                                "expected_value": {
                                                    "operator": "<",
                                                    "value": 45,
                                                    "unit": "years"
                                                }
                                            }
                                        },
                                        {
                                            "exact_snippets": "adequate hepatic function as defined in the inclusion/exclusion criteria is confirmed",
                                            "criterion": "hepatic function",
                                            "requirement": {
                                                "requirement_type": "adequacy",
                                                "expected_value": true
                                            }
                                        }
                                    ]
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "fatty liver",
                                "criterion": "fatty liver disease",
                                "requirement": {
                                    "requirement_type": "presence",
                                    "expected_value": true
                                }
                            },
                            {
                                "not_criteria": {
                                    "and_criteria": [
                                        {
                                            "exact_snippets": "Patients < 45 years old with fatty liver disease may be accepted as long as adequate hepatic function ... is confirmed",
                                            "criterion": "age",
                                            "requirement": {
                                                "requirement_type": "value",
                                                "expected_value": {
                                                    "operator": "<",
                                                    "value": 45,
                                                    "unit": "years"
                                                }
                                            }
                                        },
                                        {
                                            "exact_snippets": "adequate hepatic function as defined in the inclusion/exclusion criteria is confirmed",
                                            "criterion": "hepatic function",
                                            "requirement": {
                                                "requirement_type": "adequacy",
                                                "expected_value": true
                                            }
                                        }
                                    ]
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "13. Clinically significant cardiac condition, including myocardial infarction, uncontrolled angina, cerebrovascular accident, or other acute uncontrolled heart disease less than 3 months prior to enrollment.",
                "criterions": [
                    {
                        "exact_snippets": "Clinically significant cardiac condition, including myocardial infarction, uncontrolled angina, cerebrovascular accident, or other acute uncontrolled heart disease less than 3 months prior to enrollment.",
                        "criterion": "clinically significant cardiac condition",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Clinically significant cardiac condition, including myocardial infarction, uncontrolled angina, cerebrovascular accident, or other acute uncontrolled heart disease less than 3 months prior to enrollment.",
                        "criterion": "clinically significant cardiac condition",
                        "requirement": {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<",
                                "value": 3,
                                "unit": "months"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Clinically significant cardiac condition, including myocardial infarction, uncontrolled angina, cerebrovascular accident, or other acute uncontrolled heart disease less than 3 months prior to enrollment.",
                        "criterion": "clinically significant cardiac condition",
                        "requirement": {
                            "requirement_type": "examples",
                            "expected_value": [
                                "myocardial infarction",
                                "uncontrolled angina",
                                "cerebrovascular accident",
                                "other acute uncontrolled heart disease"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "6. Prior or concurrent malignancies. Exceptions per protocol.",
                "criterions": [
                    {
                        "exact_snippets": "Prior or concurrent malignancies",
                        "criterion": "malignancies",
                        "requirement": {
                            "requirement_type": "temporal occurrence",
                            "expected_value": [
                                "prior",
                                "concurrent"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        }
    ],
    "failed_miscellaneous": []
}